Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New Stanford diagnostic test for rare leukemia appears to give faster results

07.10.2008
A new twist on a well-known cell sorting technique may allow physicians to diagnose rare leukemias in hours instead of weeks, according to a study by researchers at the Stanford University School of Medicine and UC-San Francisco.

The clinical promise of the Stanford-developed approach, which eavesdrops on individual cells to decipher potentially dangerous molecular conversations, is likely to extend to many other disorders in which cell-signaling pathways are disrupted.

"We've eliminated a big bottleneck," said postdoctoral scholar Nikesh Kotecha, PhD, of the work. Kotecha, the lead author of the study, conducted the work as a graduate student in the laboratory of immunologist Garry Nolan, PhD, a co-senior author of the paper. "Now we can use this signaling assay to confirm a diagnosis much more quickly."

The study will be featured on the cover of the Oct. 7 issue of Cancer Cell. In addition to Nolan, who is an associate professor of microbiology and immunology as well as a member of Stanford's Cancer Center, the other senior co-author is Mignon Loh, MD, an associate professor of clinical pediatrics at UCSF.

"We couldn't have done this research without involving immunology, signaling biology, medicine, statistics and informatics," said Kotecha, who completed his PhD in biomedical informatics. "It's a true example of the strengths of translational research, bringing laboratory bench work and informatics to address a clinical problem."

The multidisciplinary technique builds on an experimental technique called flow cytometry, in which fluorescently labeled antibodies are used to classify and sort cells based on proteins displayed on their outer surface. The new approach, developed in Nolan's lab in 2004, creates small holes in the cell membrane prior to sorting. These holes allow other antibodies to enter the cell and bind to signaling molecules involved in the cell's internal monologue — in this case, a protein called STAT5. Kotecha and his collaborators used an antibody that binds only to the activated, or phosphorylated, version of the protein to determine the signaling status of the pathway in individual cells exposed to a variety of conditions.

The effect is somewhat like moving through an airport security line that screens travelers not just for weapons concealed outside their bodies, but also for their emotional states: "Happy to be headed home" in one line, "afraid of flying" in another and just plain "cranky" in another. Combine the two measurements — the availability of a weapon and the mood of the person carrying it — and you have a more reliable assessment of risk than with either one alone.

The researchers tested the technique's clinical value by applying it to the diagnosis of a difficult diagnostic problem: juvenile myelomonocytic leukemia, or JMML. Children with the relatively rare disorder typically have fevers, grow poorly, suffer from infections and generally look like they could have any one of a number of different diseases. A prompt diagnosis of JMML is particularly important because, unlike other leukemias, the only cure is a bone marrow transplant.

One of the few reliable indicators of JMML cells is their tendency to proliferate in response to very low levels of a growth-stimulating factor called GM-CSF; normal cells respond only at higher levels. But it can take two to three weeks to grow enough cells in the laboratory to get a definitive answer to this test.

Kotecha knew that GM-CSF activates a particular cellular signaling cascade called the JAK-STAT pathway. Although that pathway had not previously been directly implicated in JMML, Kotecha used an antibody that binds only to activated STAT5 to determine whether the cells of 12 patients with JMML displayed abnormally high levels of the protein in response to low doses of GM-CSF. Eleven of the 12 did so — confirming the involvement of the STAT pathway in the disorder.

"I was surprised how much more we can learn about the inner nature of these cells by 'interrogating' them with different conditions," said Nolan, who is also a member of the Donald E. and Delia B. Baxter Laboratory in Genetic Pharmacology at Stanford. "Time and again we are finding this to be a powerful amplifier of the fate of a diseased cell and a good way to understand why it responds to certain treatments and not others."

In contrast to the JMML samples, seven out of eight normal bone marrow samples, as well as eight out of eight samples from patients with similar, but not identical, disorders, maintained normal levels of activated protein after the low dose GM-CSF treatment — suggesting that the technique may be a sorely needed diagnostic aid for JMML.

The new technique also offers a way to monitor disease progress. With further refinement, the researchers hope that the technique can be used to screen the effectiveness of potential drugs for treatment of JMML and other disorders.

"Identifying populations of cells by their response to specific stimuli will facilitate our ability to assess the efficacy of specific agents in relevant subsets with increased precision," said Loh. "In an era of using increasingly sophisticated targeted agents, we hope that these studies will allow investigators to more fully appreciate the specificities of their therapies."

Krista Conger | EurekAlert!
Further information:
http://www.stanford.edu

More articles from Studies and Analyses:

nachricht Study relating to materials testing Detecting damages in non-magnetic steel through magnetism
23.07.2018 | Technische Universität Kaiserslautern

nachricht Innovative genetic tests for children with developmental disorders and epilepsy
11.07.2018 | Christian-Albrechts-Universität zu Kiel

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Color effects from transparent 3D-printed nanostructures

New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference

Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

 
Latest News

Smallest transistor worldwide switches current with a single atom in solid electrolyte

17.08.2018 | Physics and Astronomy

Robots as Tools and Partners in Rehabilitation

17.08.2018 | Information Technology

Climate Impact Research in Hannover: Small Plants against Large Waves

17.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>